Graduate student and Der and Bryant lab member, Jonathan DeLiberty presents on Friday, March 25th at noon. This presentation, part of the UNC Pharmacology Graduate Student Research Seminar Series, will be on Characterization of autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma. Best of luck, Jonathan!
The labs of Der, Cox, Bryant, Pylayeva-Gupta and Yeh gathered outside of the Mary Ellen Jones building on Thursday, November 18th for the National Day of Pancreatic Cancer Awareness, part of the larger Pancreatic Cancer Awareness Month. The Der/Cox/Bryant supergroup dresses in purple all month long to promote awareness of the topic. Thank you for … Continue reading Der Lab Wears Purple for Pancreatic Cancer
Amber Amparo and Kayla Snare raised money for cancer research.
Congratulations to the Der/Cox/Bryant Lab Supergroup for particpating in this year's PanCAN PurpleStride! Although the 5K race was virtual, the impact was real; the Running RAScals raised a total of $10,211 (second place overall). Dr. Kirsten Bryant as the second-highest individual fundraiser, with a total of $6,606. This was the Running RAScals' seventh year … Continue reading PanCAN PurpleStride 2020
The UNC Computational Medicine Program sought collaborative proposals from research areas in Cognitive Computing/Machine Learning; Image Analysis/Computer Vision; Computational and Mathematical Modeling; Bioinformatics and Computational Genomics; Health Informatics and Network Analysis. Channing Der and Co-PI, Jeremy Purvis, won for “A topological model of the cell cycle in KRAS-driven cancers." You can read more about Dr. … Continue reading Der Named Computational Medicine Program 2020 Pilot Award Winner
Come out to support Aaron Hobbs as he presents "Atypical KRASG12R mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer." The talks will be held in the Pagano Conference Room on Monday, December 16th at 12:00 pm.
Channing Der has been named a Fellow of the American Association for the Advancement of Science (AAAS) for “distinguished contributions to the field of cancer research through the discovery of RAS in cancer and the elucidation of RAS oncoprotein function and therapies.” Der, who joined the UNC School of Medicine in 1992 as an associate … Continue reading Channing Der Named AAAS Fellow
Cancer survivors, patients, caregivers, and friends, gathered for an awareness reception at Hollings Cancer Center at the Medical University of South Carolina (MUSC). Dr. Channing Der spoke on the latest developments in pancreatic cancer research and treatments. More on the event at MUSC.
Two new drugs finally hit ‘undruggable’ cancer target, providing hope for treatments By Jocelyn Kaiser Cancer researchers are making progress toward a goal that has eluded them for more than 30 years: shrinking tumors by shutting off a protein called KRAS that drives growth in many cancer types. A new type of drug aimed at KRAS … Continue reading Channing Der Interviewed by Science Magazine
Congratulations to Der Lab member, Clint Stalnecker, for winning first place in an oral research presentation competition at the 44th Annual Postdoc-Faculty Research Day! Read more about the 44th Annual Postdoc Faculty Research Day.